News
-
-
-
-
-
PRESS RELEASE
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
Abbott announces results from the FreeDM2 study showing that FreeStyle Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management. Real-time insights led to better outcomes -
-
PRESS RELEASE
KAP AG GENERATES NORMALISED EBITDA WITHIN THE GUIDANCE FORECAST IN THE 2025 FINANCIAL YEAR IN A CHALLENGING MARKET ENVIRONMENT
KAP AG generates normalised EBITDA within the guidance forecast for the 2025 financial year despite challenges in the market environment. Efficiency measures reviewed for sustainable turnaround -
-
-